Since Gemcitabine enhanced the expression of NKG2D ligands in NSCLC cells, we evaluated if Gemcitabine would affect their sensitivity to NK cell-mediated cytotoxicity. This evidence concerns the gene KLRK1 and non-small cell lung carcinoma.